Enveric Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ENVB and other ETFs, options, and stocks.

About ENVB

Enveric Biosciences, Inc. is a biotechnology company which engages in the development of neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company was founded on February 28, 1994 and is headquartered in Cambridge, MA. 

CEO
Joseph Tucker
CEOJoseph Tucker
Employees
5
Employees5
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
1994
Founded1994
Employees
5
Employees5

ENVB Key Statistics

Market cap
4.23M
Market cap4.23M
Price-Earnings ratio
-0.07
Price-Earnings ratio-0.07
Dividend yield
Dividend yield
Average volume
600.75K
Average volume600.75K
High today
$0.6962
High today$0.6962
Low today
$0.669
Low today$0.669
Open price
$0.6959
Open price$0.6959
Volume
231.16K
Volume231.16K
52 Week high
$8.33
52 Week high$8.33
52 Week low
$0.5606
52 Week low$0.5606

ENVB News

TipRanks 6d
Enveric Biosciences completes key manufacturing milestones for EB-003

Enveric Biosciences (ENVB) announced significant progress in the chemistry, manufacturing, and controls development of its lead candidate, EB-003. The company s...

People also own

Based on the portfolios of people who own ENVB. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.